Drugs News and Research

RSS

Anti-malarial drug treatment given to infants can protect them for two years

Giving children intermittent preventative treatment against malaria under the age of one can protect them from the disease in their second year of life, suggests a study in this week’s issue of The Lancet.

21 Apr 2005

Anti-malarial drug combo could help address malaria crisis in Africa

Using a combination of two drugs—artemether and lumefantrine—is the most effective way to treat malaria in the areas of Africa where resistance to commonly used malaria drugs is high, concludes a randomised trial published in this week’s issue of The Lancet.

21 Apr 2005

Who needs health care - the well or the sick?

Shifting drug spending from the worried well in rich countries to those with treatable disease in poorer nations will benefit the health of everyone, argues a doctor in this week's BMJ.

21 Apr 2005

“Virtual Colonoscopy” effective in finding most polyps but may miss small ones

A type of noninvasive “virtual colonoscopy” can diagnose medium to large polyps as well as traditional colorectal probes can, but it may miss some smaller yet potentially cancerous growths, according to a new review of studies.

21 Apr 2005

Genes influence how heart failure patients respond to drugs

Genes dictate the color of our hair and eyes. They factor into whether we get cancer or heart disease. And, scientists increasingly recognize, they also ensure some patients will benefit from a prescription drug, while others develop adverse reactions or simply fail to respond at all.

21 Apr 2005

Global Health Service needed to fight AIDS

A report by the non-partisan Institute of Medicine is calling for the creation of a U.S. Global Health Service comprised of doctors, nurses and other health care workers to help combat HIV/AIDS in the world's hardest hit countries.

20 Apr 2005

Overweight not as bad as once thought

Being overweight may not be very good for you but it now seems it is nowhere near as big a killer as the US government once thought.

20 Apr 2005

Missing samples of deadly flu strain now found

World Health Organization (WHO) officials say that all but one of the deadly flu virus samples mistakenly sent to labs outside the United States have been destroyed.

20 Apr 2005

Breast cancer gene may play a major role in the recurrence of prostate cancer

A gene associated with breast cancer also may play a major role in the recurrence of prostate cancer, according to new research from the University of North Carolina at Chapel Hill School of Medicine and UNC Lineberger Comprehensive Cancer Center.

20 Apr 2005

Arthritis medications (methotrexate and leflunomide) commonly used in adults are safe and effective in children

An international team of researchers, led by Dr. Earl Silverman of The Hospital for Sick Children (Sick Kids), has found that two arthritis medications (methotrexate and leflunomide) commonly used in adults are safe and effective in children. This research is reported in the April 21, 2005 issue of The New England Journal of Medicine.

20 Apr 2005

Discovery of brain's first known 'safety circuit' gives new perspective on anxiety disorders

Scientists at Columbia University Medical Center have made a surprising finding about positive emotions that should change the way people think about anxiety disorders.

20 Apr 2005

Electroshock therapy speeds improvement in schizophrenia patients

Shock therapy, a controversial practice conjuring frightening images of behavior control, still has a place in schizophrenia treatment, a newly updated research review shows.

20 Apr 2005

Brain-injury rehabilitation depends on acetylcholine circuitry

The ability of the brain to recover from such injury as stroke or trauma depends on a particular circuitry of neurons that "talk" to one another using the brain chemical acetylcholine, researchers led by James Conner and Mark Tuszynski in the Neural repair Group at UCSD have discovered.

20 Apr 2005

Researchers find ovarian cancer patients who appear to respond better than others to gefitinib, or Iressa

Researchers at Fox Chase Cancer Center in Philadelphia have identified a subset of ovarian cancer patients who appear to respond better than others to gefitinib, or Iressa. The research was presented today at the 96th Annual Meeting of the American Association for Cancer Research in Anaheim, Calif.

20 Apr 2005

New method for obtaining sequence information from thousands of genomes simultaneously

One of the world’s leading scientists, Nobel Prize winner, Dr Sydney Brenner, has devised a new method for obtaining sequence information from thousands of genomes simultaneously. Current technologies can only analyse one genome at a time.

20 Apr 2005

Heart attack victims face increased risk of death with Natrecor

In a recent study Jonathan Sackner-Bernstein, a doctor at North Shore University Hospital in New York says that Natrecor, heart failure treatment produced by drug company Johnson & Johnson may be linked to a greater risk of death when compared with standard therapy.

20 Apr 2005

New era drug gives hope to Gleevec resistant leukaemia sufferers

Gleevec, a drug regarded by many as having "wonder drug" capabilities in the treatment of chronic myelogenous leukaemia (CML) and other cancers, has been revealed as having shortcomings in that some patients have undergone a relapse after building a resistance to the drug. For others with the advanced stage of the disease, the drug has failed to produce durable remissions.

19 Apr 2005